C07H5/02

METHOD FOR PREPARING SUCRALOSE CRUDE PRODUCT BY USING ALCOHOL-WATER ALKALINE HYDROLYSIS SYSTEM
20250243230 · 2025-07-31 ·

The present invention provides a preparation method of a sucralose crude product by using an alcohol-water alkaline hydrolysis system, and relates to the technical field of fine chemical engineering. In the present invention, an aqueous solution of sucralose-6-acetate crude product is taken as a raw material, and is subjected to alkaline hydrolysis in an alkali metal hydroxide and methanol-water system, such that sucralose-6-acetate and chlorosucrose ester impurities (sucralose diester and tetrachlorosucrose-6-acetate) in the aqueous solution of sucralose-6-acetate crude product are both converted into sucralose, thereby significantly improving the yield of sucralose. In the present invention, separation is realized by carrying out multiple instances of concentration and multiple instances of extraction-back extraction in an ethyl acetate/water double-solvent system, such that fat-soluble impurities and water-soluble impurities are balanced in the system, and the phenomenon of saccharide coking during the concentration process can be avoided, thereby fully crystallizing sucralose in ethyl acetate, improving the yield of sucralose, efficiently separating inorganic salts from sucralose, and reducing the treatment cost of subsequent high-salinity wastewater.

METHOD FOR PREPARING SUCRALOSE CRUDE PRODUCT BY USING ALCOHOL-WATER ALKALINE HYDROLYSIS SYSTEM
20250243230 · 2025-07-31 ·

The present invention provides a preparation method of a sucralose crude product by using an alcohol-water alkaline hydrolysis system, and relates to the technical field of fine chemical engineering. In the present invention, an aqueous solution of sucralose-6-acetate crude product is taken as a raw material, and is subjected to alkaline hydrolysis in an alkali metal hydroxide and methanol-water system, such that sucralose-6-acetate and chlorosucrose ester impurities (sucralose diester and tetrachlorosucrose-6-acetate) in the aqueous solution of sucralose-6-acetate crude product are both converted into sucralose, thereby significantly improving the yield of sucralose. In the present invention, separation is realized by carrying out multiple instances of concentration and multiple instances of extraction-back extraction in an ethyl acetate/water double-solvent system, such that fat-soluble impurities and water-soluble impurities are balanced in the system, and the phenomenon of saccharide coking during the concentration process can be avoided, thereby fully crystallizing sucralose in ethyl acetate, improving the yield of sucralose, efficiently separating inorganic salts from sucralose, and reducing the treatment cost of subsequent high-salinity wastewater.

PROCESS FOR THE PRODUCTION OF DATH AND INTERMEDIATES THEREOF0
20250333430 · 2025-10-30 ·

The present technology is direct to methods of producing 6,6-diamino-6,6-deoxy-trehalose (DATH) or a salt thereof. The methods include optionally protecting one or more hydroxyl groups of D-trehalose and converting the primary hydroxyl groups of D-trehalose to product DATH or a salt thereof through use of a halogen, azide, and/or protected amine to. The present technology is also direct to intermediate products of the methods.

PRODUCTION OF GLYCOSYL FLUORIDES

The present invention relates to a novel and efficient method for the production of glycosyl fluorides by the fluorination of a protected saccharide with a fluorinating agent, such as poly(hydrogen fluoride), triethylamine trihydrofluoride, and DMPU-HF, wherein the fluorination is performed in the presence of a Lewis acid.

PRODUCTION OF GLYCOSYL FLUORIDES

The present invention relates to a novel and efficient method for the production of glycosyl fluorides by the fluorination of a protected saccharide with a fluorinating agent, such as poly(hydrogen fluoride), triethylamine trihydrofluoride, and DMPU-HF, wherein the fluorination is performed in the presence of a Lewis acid.

Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series

A method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, which method includes carrying out a first synthesis run comprising the steps of: a) providing water containing 18F; b) trapping the 18F from the water provided in step a) on an anion exchange material; c) eluting the trapped 18F from the anion exchange material to a reaction vessel of first radiopharmaceutical synthesis cassette; d) preparing a radiopharmaceutical incorporating the eluted 18F using the first radiopharmaceutical synthesis cassette; where steps a)-d) are repeated in at least one subsequent run using another radiopharmaceutical synthesis cassette; and where the method includes a reconditioning step of treating the anion exchange material with water between two consecutive runs. Other aspects of the invention relate to a device for performing this method, and a cassette for use in the device.

Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series

A method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, which method includes carrying out a first synthesis run comprising the steps of: a) providing water containing 18F; b) trapping the 18F from the water provided in step a) on an anion exchange material; c) eluting the trapped 18F from the anion exchange material to a reaction vessel of first radiopharmaceutical synthesis cassette; d) preparing a radiopharmaceutical incorporating the eluted 18F using the first radiopharmaceutical synthesis cassette; where steps a)-d) are repeated in at least one subsequent run using another radiopharmaceutical synthesis cassette; and where the method includes a reconditioning step of treating the anion exchange material with water between two consecutive runs. Other aspects of the invention relate to a device for performing this method, and a cassette for use in the device.

RADIOLABELED FRUCTOSE DERIVATIVES FOR MEDICAL IMAGING

There are provided fructose-based radiopharmaceuticals, pharmaceutical compositions comprising same, methods for preparing same, and methods of using same for biomedical imaging, particularly nuclear imaging using PET or PET/CT. (Compound 7)

##STR00001##

RADIOLABELED FRUCTOSE DERIVATIVES FOR MEDICAL IMAGING

There are provided fructose-based radiopharmaceuticals, pharmaceutical compositions comprising same, methods for preparing same, and methods of using same for biomedical imaging, particularly nuclear imaging using PET or PET/CT. (Compound 7)

##STR00001##